Serum YB-1 links dyslipidemia to NET-mediated vascular calcification in hemodialysis
Serum YB-1 is a novel predictor and potential mechanistic mediator of VC in MHD patients. Incorporating YB-1 into existing clinical risk models may support earlier recognition of individuals at elevated cardiovascular risk and inform more effective management strategies to improve long-term health outcomes.
Authors
- Shuan Zhao (ORCID: https://orcid.org/0000-0002-1412-4333)
- Jiaxin Chen (ORCID: https://orcid.org/0000-0002-3507-6991)
- Jieru Cai
- Jianzhou Zou
- Jialin Wang
- Nana Song
- Jian Zhang
- Zhen Zhang
- Bo Shen
- Li Wang
- Jie Teng
- Xiaoqiang Ding
- Yi Fang
- Xuesen Cao
Institutions
- Fudan University (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
Publication Details
- Journal
- Lipids in Health and Disease
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1186/s12944-025-02832-y
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00